Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Arthritis, Psoriatic 2Adenomatous Polyposis Coli 1

Interventions

guselkumab 2Etanercept 2tofacitinib 1Vaccines 1Saline Solution 1Infliximab 1Herpes Zoster Vaccine 1Adalimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Arthritis, Psoriatic × guselkumab × Clear all
NCT03796858 2025-02-03

COSMOS

Janssen Pharmaceutica N.V., Belgium

Phase 3 Completed
285 enrolled

Arthritis, Psoriatic

NCT03162796 2021-02-03

Discover-1

Janssen Research & Development, LLC

Phase 3 Completed
383 enrolled 106 charts

Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡